|
|
|
| 【主 题】 ： |
Cryopreserved Human Cord Blood CD34+ Progenitor Cells, Pooled: 100,000 cells/via |
| 【联系人名】 ： |
Wendy |
| 【电子邮件】 ： |
contact@creative-bioarray.com |
| 【联系电话】 ： |
1-631-626-9181 |
| 【发布日期】 ： |
2015-1-26 |
| 【详细说明】 ： |
CD34 is a well-known marker for primitive and bone
marrow-derived progenitor cells, especially for
hematopoietic and endothelial progenitors. Bioarray
offers CD34+ progenitor cells in a phenotypically
undifferentiated state. The progenitor cells are
derived from cord blood of healthy donors and
produced at the Bioarray facility. Progenitor cells
contain two main cellular subpopulations,
hematopoietic and endothelial progenitor cells.
CD34+ progenitor cells are suitable for a series of
studies for directed differentiation into more
committed types of blood cells and endothelial
lineages. Immediately after isolation, the freshly
prepared CD34+ progenitor cells are cryopreserved
using a serum-free freezing medium.
Samples
from each donor are tested via PCR to confirm non-
reactivity.
Cord blood CD133+ cells are
isolated using direct positive immunomagnetic
selection for CD133+ cells. The majority of CD133+
cells also express CD34. CD133 is a glycoprotein
with sub-cellular localization in plasma membrane
protrusions. In humans, this protein was originally
identified as an antigenic marker expressed on
hematopoietic stem cells. In addition, these cells
are highly proliferative primitive hematopoietic
progenitors. They can give rise to mature terminally
differentiated hematopoietic cells by means of
directed differentiation.
Bioarray offers CD133
cells in a phenotypically undifferentiated state.
The cells are derived from fresh cord blood of
healthy donors and produced at the Bioarray
facility. Immediately after isolation, the freshly
prepared CD133 cells are cryopreserved using a
serum-based cryopreservation medium. Each vial
contains 100,000 cells per vial.
|
|
|
|
|
English
